Amplitude Surgical Announces Its 2024-25 Financial Calendar

VALENCE, France--(BUSINESS WIRE)--Regulatory News:

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its financial agenda for the 2024-25 financial year.

Events	Dates *
2024-25 Q1 Sales	Thursday, November 21, 2024
2024-25 H1 Sales	Thursday, February 20, 2025
2024-25 H1 Results	Wednesday, March 26, 2025
2024-25 Q3 Sales	Thursday, April 17, 2025
2024-25 Full-year Sales	Thursday, July 24, 2025
2024-25 Full-Year results	Wednesday, October 22, 2025
2025-26 Q1 Sales	Thursday, November 20, 2025

* Subject to change. Press releases are published after market close.

Next press release:
2024-25 Q1 Sales: Thursday, November 21, 2024, after market close.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player in the global market for orthopedic surgical technologies for the lower limbs. Amplitude Surgical develops and markets high-end products for orthopedic surgery, covering the main pathologies affecting the hip and knee. Working in close collaboration with surgeons, Amplitude Surgical develops numerous high value-added innovations to meet the needs of patients, surgeons and care facilities. A leading player in France, Amplitude Surgical is expanding internationally through its subsidiaries and a network of agents and exclusive distributors in over 30 countries. At June 30, 2024, Amplitude Surgical employed 428 people and generated sales of nearly 106.0 million euros.